Cite
HARVARD Citation
Heilmann, T. et al. (2020). Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients. International journal of biological markers. 35 (2), pp. 20-28. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Heilmann, T. et al. (2020). Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients. International journal of biological markers. 35 (2), pp. 20-28. [Online].